학술논문

A first-time-in-human study of GSK2636771, a phosphoinositide 3 kinase beta-selective inhibitor, in patients with advanced solid tumors
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 1 October 2017, 23(19):5981-5992)
Subject
Language
English
ISSN
15573265
10780432